Prelude Therapeutics Inc (PRLD) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$99.50M | +21.8% |
| 2024 | -$127.17M | -4.4% |
| 2023 | -$121.83M | -5.5% |
| 2022 | -$115.44M | -3.4% |
| 2021 | -$111.69M | -96.2% |
| 2020 | -$56.93M | -106.5% |
| 2019 | -$27.57M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$99.50M | +21.8% |
| 2024 | -$127.17M | -4.4% |
| 2023 | -$121.83M | -5.5% |
| 2022 | -$115.44M | -3.4% |
| 2021 | -$111.69M | -96.2% |
| 2020 | -$56.93M | -106.5% |
| 2019 | -$27.57M | — |